Mainstream

Xtant Medical outlines 8–11% revenue growth target for 2025 as company completes vertical integration and launches new products

Xtant Medical outlines 8–11% revenue growth target for 2025 as company completes vertical integration and launches new products

Post ContentxtntRead More

You might also be interested in reading Judge rejects Kraken’s bid to challenge decision in SEC case.

May 13, 2025
In Mainstream